XAGE (Longevity Health Holdings) 3-Year ROIIC % : 36.57% (As of Dec. 2025) — 24% Above Median


XAGE Longevity Health Holdings Inc XAGE
6 GF Score
Price $0.26
! 3 Warning Signs
View Full Analysis

What is Longevity Health Holdings 3-Year ROIIC %?

Longevity Health Holdings XAGE 6 3-Year ROIIC % is 36.57 as of Dec. 2025, which is 24% above its 10-year median of 29.38. GuruFocus rates XAGE with a GF Score™ of 6/100. The stock has 3 warning signs investors should review. Among 1,830 Consumer Packaged Goods companies, Longevity Health Holdings ranks better than 81.91% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Longevity Health Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 36.57%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Longevity Health Holdings's 3-Year ROIIC % or its related term are showing as below:

XAGE's 3-Year ROIIC % is ranked better than
81.91% of 1830 companies
in the Consumer Packaged Goods industry
Industry Median: 2.86 vs XAGE: 36.57

Longevity Health Holdings  (OTCPK:XAGE) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Longevity Health Holdings 3-Year ROIIC % Related Terms


Longevity Health Holdings 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Longevity Health Holdings's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Health Holdings 3-Year ROIIC % Chart

Longevity Health Holdings Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
3-Year ROIIC %
0.00 0.00 0.00 22.18 36.57

Longevity Health Holdings Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 36.57 0.00

XAGE vs SNBH, SKVI, PG: 3-Year ROIIC % Comparison

For the Household & Personal Products subindustry, Longevity Health Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Longevity Health Holdings 3-Year ROIIC % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Longevity Health Holdings's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Longevity Health Holdings's 3-Year ROIIC % falls into.


XAGE
6GF Score
Longevity Health Holdings Inc XAGE
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longevity Health Holdings 3-Year ROIIC % Calculation

Longevity Health Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -7.108 (Dec. 2025) - -5.508 (Dec. 2022) )/( 1.419 (Dec. 2025) - 5.794 (Dec. 2022) )
=-1.6/-4.375
=36.57%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 36.57 mean?
Longevity Health Holdings (XAGE) has a 3-Year ROIIC % of 36.57 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Longevity Health Holdings and its competitors. This is 24% above median its historical median of 29.38. Over the past decade, Longevity Health Holdings' 3-Year ROIIC % has ranged from 22.18 to 36.57. According to the industry distribution chart, Longevity Health Holdings ranks #331 out of 1830 companies in the Consumer Packaged Goods industry, placing it in the top 18.1%.
Is Longevity Health Holdings' 3-Year ROIIC % too high?
Longevity Health Holdings' current 3-Year ROIIC % of 36.57 is 24% above median its 10-year median of 29.38. Over the past 10 years, this metric has ranged from a low of 22.18 to a high of 36.57. The Consumer Packaged Goods industry median 3-Year ROIIC % is 2.86. Longevity Health Holdings' value of 36.57 is 1178.7% above this industry median. Based on the distribution chart, Longevity Health Holdings ranks #331 out of 1830 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Longevity Health Holdings has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Longevity Health Holdings' 3-Year ROIIC % compare to SNBH and SKVI?
According to the Consumer Packaged Goods industry distribution chart, Longevity Health Holdings ranks #331 out of 1830 companies for 3-Year ROIIC %. This places Longevity Health Holdings in the top 18% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 2.86. Longevity Health Holdings' value of 36.57 is 1178.7% above this benchmark. Historically, Longevity Health Holdings' own 3-Year ROIIC % has ranged from 22.18 to 36.57 over the past decade. While the company's 10-year median is 29.38 vs. the industry median of 2.86, Longevity Health Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Consumer Packaged Goods company?
The median 3-Year ROIIC % among Consumer Packaged Goods companies is 2.86, based on 1,830 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Longevity Health Holdings's current 3-Year ROIIC % of 36.57 is 1178.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Longevity Health Holdings and its competitors. For the Consumer Packaged Goods industry, the median 3-Year ROIIC % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Health Holdings's current 3-Year ROIIC % is 36.57, which is 24% above median its own 10-year median of 29.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Health Holdings stock overvalued right now?
Longevity Health Holdings (XAGE) has a current 3-Year ROIIC % of 36.57. The current 3-Year ROIIC % is 36.57, which is 24% above median its 10-year median of 29.38 and 1178.7% above the Consumer Packaged Goods industry median of 2.86. Longevity Health Holdings' overall GF Score™ is 6/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Longevity Health Holdings (XAGE), the current 3-Year ROIIC % is 36.57 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Health Holdings Business Description

Address 2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203
Longevity Health Holdings Inc is a bio-aesthetics company focused on longevity and healthy aging. The company develops cosmetic skincare and haircare products designed to support skin and hair health, tailored to meet the technical requirements of professional care providers as well as retail consumers. Its product pipeline also includes regenerative bone and tissue healing solutions, although further research and development in this area has been paused. The company markets its cosmetic products in the United States through business-to-business, direct-to-consumer, and distributor sales channels.
6GF Score

Get the complete analysis for XAGE

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price